Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma. - Othman T; Lo MM; Andreadis CB; Damon LE; Ferng TT; Gaensler KML; Lee JC; Martin TG; Olin RL; Sayre PH; Smith CC; Logan AC (Leukemia & lymphoma, 2025)